Allworth Financial’s Bionano Genomics BNGO Stock Holding History

Allworth Financial’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8	Hold	6	–	–	﹤0.01%	5157
2025 Q4	$10	Hold	6	–	–	﹤0.01%	4952
2025 Q3	$11	Hold	6	–	–	﹤0.01%	4862
2025 Q2	$20	Hold	6	–	–	﹤0.01%	4518
2025 Q1	$26	Sell	6 -1	-14%	-$7	﹤0.01%	4003
2024 Q4	$75	Hold	7	–	–	﹤0.01%	3855
2024 Q3	$182	Buy	+7	New	+$218	﹤0.01%	3617
2023 Q3	–	Sell	-1	Closed	-$244	–	3448
2023 Q2	$244	Hold	1	–	–	﹤0.01%	3055
2023 Q1	$444	Hold	1	–	–	﹤0.01%	2863
2022 Q4	$584	Hold	1	–	–	﹤0.01%	2597
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	2320
2022 Q2	$1K	Hold	1	–	–	﹤0.01%	2097
2022 Q1	$1K	Buy	+1	New	+$1.35K	﹤0.01%	1884
2021 Q3	–	Sell	-3	Closed	-$15K	–	1861
2021 Q2	$15K	Hold	3	–	–	﹤0.01%	916
2021 Q1	$16K	Buy	+3	New	+$16.9K	﹤0.01%	847

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Allworth Financial's BNGO Position: Q1 2026 in Review

Allworth Financial held its Bionano Genomics (BNGO) position steady in Q1 2026 at 6 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #5157.

Allworth Financial first reported a position in BNGO in Q1 2021 and has held it in 15 quarters since. The position peaked at $16K in Q1 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

Allworth Financial held 6 shares of Bionano Genomics worth $8 as of Q1 2026.
Allworth Financial left its Bionano Genomics share count unchanged in Q1 2026.
Bionano Genomics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #5157 holding.
Allworth Financial first reported a position in Bionano Genomics in Q1 2021 and has held it in 15 quarters since.
Allworth Financial's Bionano Genomics position peaked at $16K in Q1 2021.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.